The study evaluated pesticide application records alongside the residential and workplace histories of 829 patients with the condition and 824 healthy controls. Animal testing revealed that inhaling aerosolized chlorpyrifos over an 11-week period hindered the brain's ability to clear damaged proteins, directly causing motor deficits. Uncovering this specific pathway offers scientists a clear target for developing future interventions to safeguard vulnerable neurons.
Key points
Prolonged residential exposure to chlorpyrifos is linked to more than double the risk of…: Prolonged residential exposure to chlorpyrifos is linked to more than double the risk of developing Parkinson's disease.
Despite domestic residential bans in 2001 and agricultural curbs in 2021, the chemical re…: Despite domestic residential bans in 2001 and agricultural curbs in 2021, the chemical remains actively used on domestic and international crops.
Identifying how the pesticide disrupts cellular waste clearance provides a potential foun…: Identifying how the pesticide disrupts cellular waste clearance provides a potential foundation for therapies designed to protect brain cells.
Sources checked by our analysis pipeline: 1
- Date:
- November 1, 2026
- Source:
- University of California - Los Angeles Health Sciences
- Summary:
- A UCLA study found that long-term exposure to a common pesticide was linked to more than 2.5 times the risk of Parkinson's disease. Scientists also uncovered how the chemical damages brain cells and identified a promising way to protect them.
- Share:
A pesticide used for decades in agriculture may be linked to a much greater risk of Parkinson's disease, and scientists have uncovered a possible explanation for how it damages the brain.
Researchers at UCLA Health found that people with long-term residential exposure to chlorpyrifos, a widely used pesticide, had more than 2.5 times the risk of developing Parkinson's disease compared with those who were not exposed. Laboratory experiments also revealed how the chemical can interfere with the brain's ability to remove damaged proteins, leading to the loss of nerve cells essential for controlling movement.
The study, published in Molecular Neurodegeneration, goes beyond identifying a connection between pesticide exposure and Parkinson's. By examining what happens inside affected brain cells,…
Critical diagnostic delays across NHS Wales are causing individuals to suffer worsening health outcomes as health boards grapple with a 28% consultant deficit. The Royal College of Radiologists noted this marks the first time clinical decline has been documented as a direct result of imaging wait times. Slower workforce growth driven by recruitment freezes has intensified fears that undetected malignancies will advance beyond effective treatment.
The two-time Olympian and middle-distance runner passed away after undergoing treatment for advanced-stage bowel cancer. Her death has prompted cross-border tributes from political and sporting leaders honoring her remarkable career and personal resilience. She leaves behind a storied legacy, including multiple national records across Northern Ireland and the Republic of Ireland.
Regulatory gridlock and prohibitive costs continue to block British patients with severe neurological conditions from accessing essential cannabis therapies through public healthcare. While commercial operators flourish by targeting the wider consumer wellness demographic, individuals with drug-resistant seizures face a precarious private supply chain. Without state support, vulnerable patients risk losing the specialized oils necessary to prevent life-threatening seizures.